Susan Branford, Jorge Cortés, Naoto Takahashi, Richard Larson, Ghayas Issa, Felice Bombaci, Jianxiang Wang, Dong-Wook Kim, Dennis Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Inho Kim, Gabriel Etienne, Shruti Kapoor, Rajendra Jinwal, Kamel Malek, Amila Sarac, Andreas Bruederle, Pablo Serrano-Fernandez, Pedro Milanez-Almeida, Andreas Hochhaus, Timothy Hughes. "Distinct patterns of mutant ASXL1 over time and their implications for treatment failure (TF) and BCR::ABL1 mutation development in newly diagnosed patients with chronic myeloid leukemia in chronic phase (CML-CP) treated with asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS-TKI) in the ASC4FIRST study." Blood, 2025. doi:10.1182/blood-2025-73